Cargando…
Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL(pro) inhibitors against SARS-CoV-2
A series of peptidomimetic compounds containing benzothiazolyl ketone and [2.2.1] azabicyclic ring was designed, synthesized and evaluated in the hope of obtaining potent oral 3CL(pro) inhibitors with improved pharmacokinetic properties. Among the target compounds, 11b had the best enzymatic potency...
Autores principales: | Yang, Hanxi, You, Mengyuan, Shu, Xiaoyang, Zhen, Jingyao, Zhu, Mengwei, Fu, Tiantian, Zhang, Yan, Jiang, Xiangrui, Zhang, Leike, Xu, Yechun, Zhang, Yumin, Su, Haixia, Zhang, Qiumeng, Shen, Jingshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204345/ https://www.ncbi.nlm.nih.gov/pubmed/37253309 http://dx.doi.org/10.1016/j.ejmech.2023.115512 |
Ejemplares similares
-
Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety
por: Zhu, Mengwei, et al.
Publicado: (2023) -
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021) -
Solid-Phase Synthesis of 2-Benzothiazolyl and 2-(Aminophenyl)benzothiazolyl Amino Acids and Peptides
por: Mourtas, Spyridon, et al.
Publicado: (2023) -
Preparation of Benzothiazolyl-Decorated Nanoliposomes
por: Mourtas, Spyridon, et al.
Publicado: (2019) -
Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)